Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

7 Jan 2008 07:00

Tarsus Group PLC07 January 2008 7 January 2008 TARSUS GROUP PLC TRADING UPDATE Tarsus Group plc ('Tarsus' or 'the Group'), the international media group withinterests in exhibitions, conferences, publishing and online media hascontinued to trade well in the second half of 2007 with strong performances fromall of its key products. Group like-for-like organic revenue growth for theyear to 31 December 2007 has been 15% and, as a result, the Board expects fullyear 2007 results to be towards the top end of market expectations. Labelexpo Europe, the Group's second largest exhibition, produced revenue growth10% above that of the 2005 event and rebookings for 2009 are already at 90% ofthe total 2007 event. The three important French exhibitions Heavent (event marketing), IP Convergence (IT) and Educatec (education) were all well ahead of2006 and contributed to strong like-for-like organic revenue growth from theFrench division of 14% for the year as a whole. The final medical event of theyear, Anti-Ageing Las Vegas, was a great success with revenues and attendees up35% and 30% respectively over 2006. The development of our emerging markets portfolio was significantly acceleratedwith the November 2007 acquisition of Fairs & Exhibitions Limited, whose keyevent is the Dubai Air Show. This biennial show, which is now the Group's largest, was extremely well received with visitor numbers up nearly 30% from the2005 event to 45,000 and record customer orders in excess of US$100 billion.The event will move to a new purpose-built venue in 2009 which has resulted inrequests for large upgrades in space from major exhibitors. Other emerging market events were China-focused in the second half and our keyevent, the third edition of Labelexpo Asia in Shanghai, saw revenues rise by12% above the 2005 event and visitor numbers by 54%. Rebookings are strong and well ahead of the previous cycle. Caroo, our online business, has continued its strong momentum with like-for-likeorganic revenues up by 21% for the full year. We have appointed a newdivisional CEO in the US to drive growth in that market following theacquisition of the DMS Group in July. Outlook for 2008 The broadening of the Group's base is an important step in underpinning ourability to grow consistently in the years ahead. During 2007 we have continuedto expand the number of sectors served by the Group and made good progress in diversifying our revenues geographically. Average emerging market revenues forthe 2007/2008 cycle are expected to be approximately 16% of the total up from5% for the 2005/2006 cycle. The Group is strongly second half weighted and, with the major Labelexpo showreturning to the US from Europe in 2008, dollar exposure will be higher than in2007. Our significant events in the first quarter of 2008 - the US Off-Price show, the Mod'Amont clothing accessories event in Paris and GESS (a neweducational show in Dubai) - are developing extremely well. Overall, forwardbookings are strong and the Board remains confident that 2008 will be anotheryear of strong like-for-like growth for the Group. The Group expects to announce its preliminary results for the year to 31December 2007 on 3 March 2008. Ends For further information please contact: Tarsus Group plc: Douglas Emslie: Group Managing Director: Tel 020 8846 2700 Media: Matthew Moth :Madano Partnership: Tel: 020 7593 4000 Investors: Neville Harris : IRFocus: Tel: 020 7593 4215 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Mar 20114:31 pmRNSHolding(s) in Company
17th Mar 20114:28 pmRNSAcquisition
10th Mar 201112:00 pmRNSDirector/PDMR Shareholding
7th Mar 20117:00 amRNSFinal Results
21st Jan 201110:42 amRNSAdditional Listing
18th Jan 20114:36 pmRNSHolding(s) in Company
18th Jan 20114:36 pmRNSHolding(s) in Company
6th Jan 20117:00 amRNSTrading Statement
5th Jan 20114:29 pmRNSHolding(s) in Company
5th Jan 20114:27 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSTotal Voting Rights
20th Dec 20103:02 pmRNSScrip Dividend Circular
30th Nov 20102:37 pmRNSTotal Voting Rights
16th Nov 20107:00 amRNSInterim Management Statement
9th Nov 20104:58 pmRNSBlocklisting Interim Review
17th Sep 20104:55 pmRNSChange of Registered Office
31st Aug 20109:55 amRNSTotal Voting Rights
25th Aug 20106:14 pmRNSHolding(s) in Company
25th Aug 20106:12 pmRNSHolding(s) in Company
25th Aug 20106:11 pmRNSHolding(s) in Company
25th Aug 20106:09 pmRNSHolding(s) in Company
25th Aug 20106:07 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSCompletion of Acquisition and Total Voting Rights
20th Aug 20104:14 pmRNSDirector/PDMR Shareholding
19th Aug 20101:50 pmRNSResult of Meeting
18th Aug 201010:55 amRNSInterim Financial Statements 2010
17th Aug 201010:41 amRNSDirector/PDMR Shareholding
30th Jul 201010:53 amRNSTotal Voting Rights
28th Jul 20107:01 amRNSPosting of Circular
28th Jul 20107:00 amRNSInterim Results
26th Jul 20103:22 pmRNSApplication for Admission
5th Jul 20103:55 pmRNSApplication for admission
30th Jun 20107:00 amRNSPre-close Trading Statement
17th Jun 20105:10 pmRNSDirector/PDMR Shareholding
16th Jun 20102:48 pmRNSResult of AGM
7th Jun 20102:31 pmRNSCirc re. Scrip Dividend
14th May 201012:21 pmRNSAmendment to Notice of Annual General Meeting
10th May 20104:58 pmRNSAnnual Information Update
10th May 20107:00 amRNSInterim Management Statement
7th May 201011:14 amRNSBlocklisting Six Monthly Return
30th Apr 201010:05 amRNSTotal Voting Rights
13th Apr 20105:31 pmRNSDirector/PDMR Shareholding
12th Apr 20101:36 pmRNSAnnual Reports and Accounts
9th Apr 20104:44 pmRNSHolding(s) in Company
1st Apr 20104:33 pmRNSNotification of Interests in Shares
31st Mar 20109:48 amRNSTotal Voting Rights
8th Mar 20107:00 amRNSAcquisition
8th Mar 20107:00 amRNSFinal Results
5th Mar 20107:00 amRNSDirectorate Change
22nd Feb 20107:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.